Xanthine

Xanthine

SCHEMBL7044234

Oc1nc(O)c2[nH]cnc2n1.[PbH2]

nearest known ligand 0.42

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GDA Q9Y2T3 2/20 0.42
▸ PDPK1 O15530 1/20 0.42
▸ ALDH1A1 P00352 1/20 0.40
▸ CDK2 P24941 1/20 0.40
▸ DPP4 P27487 1/20 0.40
▸ PNP P00491 1/20 0.39
▸ XDH P47989 2/20 0.37
▸ MAP3K5 Q99683 1/20 0.37
▸ CYP1A2 P05177 1/20 0.37
▸ CYP2C19 P33261 1/20 0.37
▸ HSD17B10 Q99714 1/20 0.37
▸ ADORA3 P0DMS8 2/20 0.36
▸ ADORA2A P29274 2/20 0.36
▸ ADORA1 P30542 2/20 0.36
▸ BRAF P15056 2/20 0.36
▸ PI4KA P42356 2/20 0.35
▸ PI4K2B Q8TCG2 2/20 0.35
▸ PI4K2A Q9BTU6 2/20 0.35
▸ PI4KB Q9UBF8 2/20 0.35
▸ LMNA P02545 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Xanthine SCHEMBL4966 0.98 GDA (0.44) GDAPDPK1ALDH1A1CDK2DPP4
Xanthine SCHEMBL9443819 0.98 GDA (0.44) GDAPDPK1ALDH1A1CDK2DPP4
2,6-Diaminopurine SCHEMBL6839643 0.83 PDPK1 (0.72) GDAPDPK1CDK2DPP4XDH
SCHEMBL1724116 0.82 GDA (0.41) GDAPDPK1ALDH1A1CDK2DPP4
SCHEMBL9154126 0.81 GDA (0.35) GDAPDPK1ALDH1A1CDK2DPP4
Isoguanine SCHEMBL887741 0.78 PDPK1 (0.66) GDAPDPK1CDK2DPP4PNP
SCHEMBL612211 0.78 GDA (0.41) GDAPDPK1ALDH1A1CDK2DPP4
SCHEMBL9465644 0.78 GDA (0.41) GDAPDPK1ALDH1A1CDK2DPP4
SCHEMBL1009011 0.78 XDH (0.56) GDAPDPK1CDK2DPP4XDH
SCHEMBL833645 0.78 GDA (0.41) GDAPDPK1ALDH1A1CDK2DPP4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6815213-B1 FOR DETECTING COUNTERFEITING IN MANUFACTURING PROCESSES (FINE CHEMICAL, COSMETIC, PHARMACEUTICAL); NUCLEAR MAGNETIC RESONANCE EUROFINS SCIENTIFIC (FR) 2004-11-09 — — US disclosed
Send feedback